Literature DB >> 22707727

A bipartite autoinhibitory region within the B-domain suppresses function in factor V.

Mettine H A Bos1, Rodney M Camire.   

Abstract

Activation of blood coagulation factor V (FV) is a key reaction of hemostasis. FV circulates in plasma as an inactive procofactor, and proteolytic removal of a large central B-domain converts it to an active cofactor (FVa) for factor Xa (FXa). Here we show that two short evolutionary conserved segments of the B-domain, together termed the procofactor regulatory region, serve an essential autoinhibitory function. This newly identified motif consists of a basic (963-1008) and an acidic (1493-1537) region and defines the minimal sequence requirements to maintain FV as a procofactor. Our data suggest that dismantling this autoinhibitory region via deletion or proteolysis is the driving force to unveil a high affinity binding site(s) for FXa. These findings document an unexpected sequence-specific role for the B-domain by negatively regulating FV function and preventing activity of the procofactor. These new mechanistic insights point to new ways in which the FV procofactor to cofactor transition could be modulated to alter hemostasis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22707727      PMCID: PMC3406718          DOI: 10.1074/jbc.M112.377168

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  64 in total

Review 1.  Autoinhibitory domains: modular effectors of cellular regulation.

Authors:  Miles A Pufall; Barbara J Graves
Journal:  Annu Rev Cell Dev Biol       Date:  2002-04-02       Impact factor: 13.827

2.  Proteases from Vipera lebetina venom affecting coagulation and fibrinolysis.

Authors:  J Siigur; A Aaspõllu; K Tõnismägi; K Trummal; M Samel; H Vija; J Subbi; E Siigur
Journal:  Haemostasis       Date:  2001 May-Dec

3.  The subunit structure of thrombin-activated factor V. Isolation of activated factor V, separation of subunits, and reconstitution of biological activity.

Authors:  C T Esmon
Journal:  J Biol Chem       Date:  1979-02-10       Impact factor: 5.157

4.  An anticoagulant RNA aptamer that inhibits proteinase-cofactor interactions within prothrombinase.

Authors:  Sai K Buddai; Juliana M Layzer; Genmin Lu; Christopher P Rusconi; Bruce A Sullenger; Dougald M Monroe; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

5.  Structural basis of thrombin-mediated factor V activation: the Glu666-Glu672 sequence is critical for processing at the heavy chain-B domain junction.

Authors:  María Ángeles Corral-Rodríguez; Paul E Bock; Erick Hernández-Carvajal; Ricardo Gutiérrez-Gallego; Pablo Fuentes-Prior
Journal:  Blood       Date:  2011-05-09       Impact factor: 22.113

6.  Thrombin-mediated proteolysis of factor V resulting in gradual B-domain release and exposure of the factor Xa-binding site.

Authors:  Mårten Steen; Björn Dahlbäck
Journal:  J Biol Chem       Date:  2002-08-05       Impact factor: 5.157

7.  Prothrombinase assembly and S1 site occupation restore the catalytic activity of FXa impaired by mutation at the sodium-binding site.

Authors:  Rodney M Camire
Journal:  J Biol Chem       Date:  2002-07-30       Impact factor: 5.157

Review 8.  The molecular basis of factor V and VIII procofactor activation.

Authors:  R M Camire; M H A Bos
Journal:  J Thromb Haemost       Date:  2009-09-18       Impact factor: 5.824

9.  Regulated cleavage of prothrombin by prothrombinase: repositioning a cleavage site reveals the unique kinetic behavior of the action of prothrombinase on its compound substrate.

Authors:  Harlan N Bradford; Joseph A Micucci; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2009-10-26       Impact factor: 5.157

Review 10.  Procoagulant adaptation of a blood coagulation prothrombinase-like enzyme complex in australian elapid venom.

Authors:  Mettine H A Bos; Rodney M Camire
Journal:  Toxins (Basel)       Date:  2010-06-18       Impact factor: 4.546

View more
  27 in total

1.  Factor V, tissue factor pathway inhibitor, and east Texas bleeding disorder.

Authors:  George J Broze; Thomas J Girard
Journal:  J Clin Invest       Date:  2013-08-27       Impact factor: 14.808

2.  Restoring the procofactor state of factor Va-like variants by complementation with B-domain peptides.

Authors:  Matthew W Bunce; Mettine H A Bos; Sriram Krishnaswamy; Rodney M Camire
Journal:  J Biol Chem       Date:  2013-09-06       Impact factor: 5.157

3.  Occlusion of anion-binding exosite 2 in meizothrombin explains its impaired ability to activate factor V.

Authors:  Harlan N Bradford; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2018-12-21       Impact factor: 5.157

4.  Platelets contain tissue factor pathway inhibitor-2 derived from megakaryocytes and inhibits fibrinolysis.

Authors:  Kanagasabai Vadivel; Sathya-Moorthy Ponnuraj; Yogesh Kumar; Anne K Zaiss; Matthew W Bunce; Rodney M Camire; Ling Wu; Denis Evseenko; Harvey R Herschman; Madhu S Bajaj; S Paul Bajaj
Journal:  J Biol Chem       Date:  2014-09-28       Impact factor: 5.157

5.  Interaction of factor V B-domain acidic region with its basic region and with TFPI/TFPI2: Structural insights from molecular modeling studies.

Authors:  Kanagasabai Vadivel; Yogesh Kumar; Matthew W Bunce; Rodney M Camire; Madhu S Bajaj; S Paul Bajaj
Journal:  Int Biol Rev       Date:  2017-05

6.  Factor Xa activation of factor V is of paramount importance in initiating the coagulation system: lessons from a tick salivary protein.

Authors:  Tim J Schuijt; Kamran Bakhtiari; Sirlei Daffre; Kathleen Deponte; Simone J H Wielders; J Arnoud Marquart; Joppe W Hovius; Tom van der Poll; Erol Fikrig; Matthew W Bunce; Rodney M Camire; Gerry A F Nicolaes; Joost C M Meijers; Cornelis van 't Veer
Journal:  Circulation       Date:  2013-07-01       Impact factor: 29.690

7.  Tick spit shines a light on the initiation of coagulation.

Authors:  Maria M Aleman; Alisa S Wolberg
Journal:  Circulation       Date:  2013-07-01       Impact factor: 29.690

Review 8.  Biology of tissue factor pathway inhibitor.

Authors:  Jeremy P Wood; Paul E R Ellery; Susan A Maroney; Alan E Mast
Journal:  Blood       Date:  2014-03-11       Impact factor: 22.113

9.  Coagulation factor V(A2440G) causes east Texas bleeding disorder via TFPIα.

Authors:  Lisa M Vincent; Sinh Tran; Ruzica Livaja; Tracy A Bensend; Dianna M Milewicz; Björn Dahlbäck
Journal:  J Clin Invest       Date:  2013-08-27       Impact factor: 14.808

10.  TFPIα interacts with FVa and FXa to inhibit prothrombinase during the initiation of coagulation.

Authors:  Jeremy P Wood; Helle H Petersen; Bingke Yu; Xiaoai Wu; Ida Hilden; Alan E Mast
Journal:  Blood Adv       Date:  2017-12-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.